India, July 22 -- British pharmaceutical major AstraZeneca on Tuesday unveiled a $50 billion investment plan in the United States, which includes setting up a multi-billion-dollar manufacturing facility in Virginia-its largest single investment in manufacturing to date, according to media reports.

The move comes as the Trump administration escalates pressure on foreign pharmaceutical imports through proposed steep tariffs.

The announcement coincides with US President Donald Trump intensifying his stance on imposing tariffs on drug imports-an area previously spared in earlier rounds of trade levies.

He added that the proposed measures are designed to "end this structural weakness" in the domestic pharmaceutical supply chain.

Back in Ap...